X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation

Oversubscribed round propels company towards clinical trials and global market expansion, promising to extend organ preservation times and revolutionize healthcare. SAN FRANCISCO, March 13, 2024 /PRNewswire/ — X-Therma Inc., a biotechnology company developing a breakthrough platform for…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks